News for electroCore, Inc. (ECOR)

ElectroCore, Inc. (ECOR) has unveiled promising findings at the 2025 International Brain Injury Association World Congress, showcasing the efficacy of their gam

ROCKAWAY, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. ( ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today

ROCKAWAY, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. ( ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today

ROCKAWAY, N.J., April 03, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. ( ECOR), a commercial-stage bioelectronic medicine and wellness company, has been recogni

On March 17, 2025, Thomas Errico, a Director at electroCore Inc (ECOR), purchased 6,000 shares of the company. Following this transaction, the insider now owns

Revenue: $25.2 million for 2024, up 57% from 2023.Fourth Quarter Revenue: $7 million, a 36% increase over Q4 2023.Gross Margin: 85% for 2024, compared to 83% i

Mar 12, 2025 / 09:30PM GMTOperator Greetings and welcome to the electroCore fourth-quarter and full-year 2024 earnings conference call. As part of our ongoing e

Record full year 2024 net sales of $25.2 million increased 57% over $16.0 million for the full year 2023 driven by 85% annual growth of Rx gammaCoreTMin the Uni

electroCore (ECOR) delivered earnings and revenue surprises of -17.65% and 3.28%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

**media[559088]**

Management to Attend the 37th Annual Roth Conference and the LSI USA '25 ROCKAWAY, N.J., March 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. ( ECOR), a com

ROCKAWAY, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. ( ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today t

**media[544452]**

electroCore (ECOR) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

If you are looking for stocks that are well positioned to maintain their recent uptrend, electroCore (ECOR) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

ElectroCore, Inc.'s promising growth and potential in the medical device industry makes it a strong buy with a $43 per share valuation. Learn more on ECOR stock here.

PR NewswireNEW YORK, Jan. 7, 2025 NEW YORK, Jan. 7, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following comp

electroCore Granted Five New U.S. Patents ROCKAWAY, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. ( ECOR), a commercial-stage bioelectronic medi

ElectroCore stock soars to 52-week high, hits $17.98